International Journal of Otolaryngology

International Journal of Otolaryngology / 2018 / Article

Corrigendum | Open Access

Volume 2018 |Article ID 9169414 | 1 page | https://doi.org/10.1155/2018/9169414

Corrigendum to “Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema”

Received15 Feb 2018
Accepted18 Feb 2018
Published01 Mar 2018

In the article titled “Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema” [1], there was an error in the Results section where the text reading “In multivariate logistic regression analysis, angioedema located in the head and neck region was nonsignificantly associated with admission (odds ratio (OR) 5.9 ( = 0.15, 95% CI 0.53–98.49)), while angioedema in peripheral sites was significantly associated with not being admitted (OR 0.15 ( = 0.05 95% CI, 0.01–0.95) (Table ))” should be corrected as follows.

“In multivariate logistic regression analysis, angioedema located in the head and neck region was nonsignificantly associated with admission (odds ratio (OR) 6.93 ( = 0.14, 95% CI 0.53–98.49)), while angioedema in peripheral sites was significantly associated with not being admitted (OR 0.15 ( = 0.05 95% CI, 0.01–0.95) (Table )).”

References

  1. E. Rye Rasmussen, C. von Buchwald et al., “Assessment of 105 patients with angiotensin converting enzyme-inhibitor induced angioedema,” International Journal of Otolaryngology, vol. 2017, Article ID 1476402, 7 pages, 2017. View at: Publisher Site | Google Scholar

Copyright © 2018 Eva Rye Rasmussen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

605 Views | 280 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.